REVENUE MIX - 2024 TO 20262024FRAG 20%SUPPS 80%ULTA 250 → 1,539 DOORS+98% YoY2026FRAG 85%SUPPS 15%CONCENTRATION, NOT BALANCE
StrategyBrand Founders6 min read15 July 2026

The Nue Co. Went From 20% Fragrance to 85% Fragrance in Two Years. That is What Ruthless Category Reallocation Looks Like.

The Nue Co. told Glossy on 17 July that fragrance now represents a projected 85% of revenue for 2026, up from 20% two years ago, after Ulta expansion to 1,539 doors drove 98% year on year growth and made Ulta 40% of the business. That is a case study in what it looks like when a founder actually reallocates against a retail signal, and it is a useful mirror for £500k-£5m brands sitting on category evidence they have not yet acted on.

SL
Sophie Lansbury

Beauty 2.0 Founder - 20 years in the beauty industry

The Nue Co. had two categories, one clearly winning, and the founder rebuilt the company around the winner. Most brands sitting on the same evidence build around the loser because it was the original story. If your best-selling SKU has grown three times in eighteen months and your worst-selling SKU has flatlined, the founder question is not why the flatline is happening. It is why you are still funding it.

Key takeaway

In brief
The Nue Co., founded in 2017 as a supplements-first wellness brand, told Glossy on 17 July 2026 that fragrance will make up a projected 85% of revenue in 2026, up from about 20% two years ago, with Ulta at 1,539 doors now accounting for around 40% of the business at 98% YoY growth. This post examines what that pivot actually cost inside the company, what the trigger conditions were, and why the same signal sits in most £500k-£5m portfolios but rarely gets acted on with the same discipline. The lesson is not to add fragrance. It is to read your own retail data with the same honesty.
Who this is for
Brand Founders
Main takeaway
The Nue Co. had two categories, one clearly winning, and the founder rebuilt the company around the winner. Most brands sitting on the same evidence build around the loser because it was the original story. If your best-selling SKU has grown three times in eighteen months and your worst-selling SKU has flatlined, the founder question is not why the flatline is happening. It is why you are still funding it.
What to do next
Pull your SKU-level sell-through data for the last 24 months and rank by contribution per SKU, not by revenue. If the top three SKUs contribute 70% or more of profit, run the same reallocation exercise Jules Miller ran at The Nue Co. Cut the bottom third of your range in H2 planning, redirect the shelf and marketing spend into the top decile, and hold the discipline for four quarters. It is the highest-leverage move most sub-£5m brands are not making.

The Nue Co. was founded in 2017 as a supplements-first wellness brand. Ingestible collagen, functional powders, hair growth capsules, adaptogens. It was a good story for the moment and it built a business. Founder Jules Miller told Glossy in a 17 July 2026 interview (https://www.glossy.co/beauty/the-nue-co-ulta-fragrance-growth/) that fragrance now represents a projected 85% of the company's 2026 revenue, up from about 20% two years ago. The pivot was driven by Ulta, which expanded its Nue Co. doors from around 250 to 1,539 in 12 months and now accounts for around 40% of the business. Overall growth is running at 98% year on year.

For a £500k-£5m beauty founder, this is not a story about fragrance and it is not a story about Ulta. It is a case study in what disciplined category reallocation actually looks like inside a company that had built a public identity around a different category.

Most indie brands sit on some version of the same evidence and choose not to act on it. Understanding why is where the interesting founder question lives.

The trigger was not internal opinion, it was retail data

The Nue Co. launched its first fragrance, Functional Fragrance, in 2018, positioned as a stress-reducing scent using neuroscience-linked ingredients. It was a side product to a supplements-first identity. By 2023 it had crossed into meaningful sell-through and Ulta expanded distribution.

Miller told Glossy the pivot happened when the Ulta data made the story impossible to argue with. The fragrance line was not just growing, it was growing at a rate the supplements line had never grown at, at a margin structure the supplements line could not match, in a category the retailer was actively investing shelf into. The internal debate the founder described sounded like "when do we stop pretending we are a supplements brand" not "should we add fragrance to the portfolio."

That is the useful distinction. Retailer sell-through data is objective. Founder identity is subjective. Most brand pivots stall because the founder tries to satisfy both at once and ends up doing neither category well. The Nue Co. did not try. It kept a small supplements presence for continuity and rebuilt the go-to-market around the winner.

What 20% to 85% cost operationally

Category reallocation of that magnitude is not a marketing decision. It is an operational rebuild.

Fragrance has different margin structure, different shelf presentation, different creative production requirements, different testing infrastructure (fragrance safety, IFRA compliance, allergen labelling), different retail training, different inventory turn, and different customer journey than supplements. The Nue Co. rebuilt significant portions of its supply chain and its team around the new dominant category. Supplements retention flows were downgraded. Fragrance-first email creative replaced ingestible-first creative. Retail training was retooled around scent walks rather than routine adherence.

That level of internal change is what most founders shy away from when they see the same signal. The reason most brands stay stuck in the "portfolio balance" argument is not that they cannot read the data. It is that they cannot face the operational rebuild the data implies. It is easier to argue for a diverse range than to accept that one category was always going to be the business.

The signal most £500k-£5m brands are already sitting on

Most indie beauty brands with 24 months of sell-through data have a version of this signal in their books. One SKU or one category is contributing disproportionately to profit. One SKU or one category is flatlining or eroding. The gap between the two is widening, not narrowing.

The founder response is usually a story about brand coherence, about the range serving different customer needs, or about the original vision. None of that is wrong. It is just not commercially decisive. Contribution per SKU is decisive.

The right diagnostic exercise is not complicated. Rank SKUs by contribution margin over the last 24 months. If the top three SKUs contribute more than 70% of profit, the range below them is subsidised by them. If the bottom third contributes negative or near-zero profit, it is actively costing the business shelf attention, marketing spend, and operational complexity. That is the mirror image of The Nue Co.'s Ulta signal, and it applies to nearly every sub-£5m portfolio.

Why brands do not reallocate even when the data is obvious

The three reasons founders resist category reallocation, in order of how often they show up in real conversations. First, identity. The founder built the brand around a story and the story includes categories the data does not support. Reallocating feels like admitting the original story was wrong. Second, hedging. Founders prefer optionality to concentration because concentration feels risky, even when the data shows the opposite. Third, sunk cost. Investments already made in the losing category (inventory, formulation, packaging, retail listings) feel like reasons to keep going rather than reasons to stop.

None of these hold up against the compounding advantage of doubling down on the winner. In The Nue Co.'s case, the fragrance category is now big enough to fund the operational depth that would not have been affordable at 20% share of the business. That in turn extends the lead. Reallocation is not just permissible. It is competitively necessary once the retailer signal is clear.

The reading a founder should do this month

The Nue Co. story is worth reading because it is honest about the mechanics. Miller did not describe an epiphany. She described a slow acceptance that the numbers had been telling her something for two years and that continuing to argue for portfolio balance was costing the company the compounding advantage of concentration.

For a £500k-£5m brand, the equivalent action is not to add fragrance. It is to run the ranking exercise on your own portfolio and ask which category the retailer data and the sell-through data have been pointing at for the last 18 months. Then ask why the H2 plan does not reflect it.

The most valuable planning move an indie founder can make in the next quarter is not adding new categories. It is deciding which existing category actually deserves to be the business, and cutting everything that is not it back to a maintenance line.

Miller did that at 20% and got to 85% in two years, plus 98% YoY growth. The maths of concentration are not subtle. The discipline to act on them is where most brands stop.

Share
SL

Sophie Lansbury

Founder of Beauty 2.0. Nearly 20 years in beauty — from counter to boardroom, indie launches to global houses. Writes about the operational reality of growing beauty brands.

About Sophie

The Nue Co. did not add fragrance. It made fragrance the business. When Ulta doubled the door count and the sell-through came through, the founder let the winning category expand and cut the losing ones back. Most indie brands sitting on the same signal instead argue for portfolio balance.

Var detta till hjälp?

Related posts

CLEANNATURALCLAIM LADDERCLEANNON-TOXICBIODEGRADABLEFREE-FROM PFASFILEMARKETING → SUBSTANTIATION
StrategyBrand FoundersUS7 min read

'Clean Beauty' Is Now a Class-Action Category. Every Founder Using the Word Needs a Substantiation File by End of Q3.

Active class-action suits filed in 2026 target Ulta's Conscious Beauty programme (alleged inclusion of ingredients on its own 'Made Without' list), No7 (biodegradability overstatement), and Unilever's Dove (a 0% Aluminium and no alcohol deodorant claim that allegedly contains benzyl alcohol). Multiple law firms and consumer-protection outlets are now tracking clean-beauty claims as a rising litigation category, largely filed in California, New York, and Washington. Any indie beauty brand using 'clean,' 'natural,' 'non-toxic,' 'pure,' or 'free-from' language without a formal substantiation file is running exposure. This is the moment the marketing shortcut turns into a legal liability.

11 Jul 2026Read →
ABPORTFOLIO£NEXT BRANDS
StrategyBrand FoundersUK6 min read

SLG Sold COLAB and Johnny's Chop Shop. Read It As the Cleanest UK Beauty Exit Template of the Year.

Cheltenham-based SLG Brands sold dry shampoo brand COLAB and men's grooming brand Johnny's Chop Shop to US multi-brand platform Thriving Brands on 3 July 2026, with stated intent to recycle capital into new brand creation. For a £500k-£5m UK founder thinking about a first exit, this is the clearest live template of the year: build to a retail-proven ceiling, sell the mature asset to a strategic buyer with a portfolio structure, redeploy the capital rather than trying to scale a single label indefinitely.

3 Jul 2026Read →
LOT TRACE!RECALLLOT-3BTARGETED PULL
StrategyBrand FoundersUS6 min read

Kao Just Recalled Oribe Shampoo for Bacterial Contamination. Read It Before Your Brand's Next Co-Man Deal.

Kao USA voluntarily recalled specific lots of Oribe Serene Scalp Densifying Shampoo on 1 July 2026 after detecting Pluralibacter gergoviae in product manufactured in late February 2026, per the FDA safety notice and Global Cosmetics News. A prestige haircare brand under a multinational conglomerate still landed a contamination event on shelf. For a £500k-£5m indie founder scaling into new co-manufacturing relationships, the useful read is not the recall itself. It is what the recall says about the operating discipline required once a brand crosses into national retail.

1 Jul 2026Read →